Autopsy report · NCT01233102
Mesenchymal Stem Cells Treat Liver Cirrhosis
Cause of deathNo reason given
Life of this trial
- Registered 1 year after it had already started.
- Suspended: paused, and may or may not restart.
- 200 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 1, Phase 2
- Sponsor
- Yufang Shi
- Sponsor type
- Government (non-US federal)
- Conditions
- Liver Cirrhosis
- Interventions
- Conserved Therapy; Hepatic artery infusion or Intravenous infusion
- Participants
- 200 (planned, not actual)
- Sites
- 1
- Countries
- China
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.